Product Introduction
Bioactivity


英文名: Cefuroxime sodium

描述: Cefuroxime sodium (Cefuroxime sodium salt) 是一种具有口服活性的头孢菌素抗生素，增加了对 β-内酰胺酶的稳定性。

体内活性: The intravenous LD50 of cefuroxime sodium for mice is 10.4 g/kg. The maximum dosage administered in other acute toxicity tests is well tolerated by mice (10 g/kg, subcutaneous), by rats (4 g/kg, intravenous, 5 g/kg, subcutaneous) and by cats, dogs and monkeys (2 g/kg, intramuscularly). However, when cefuroxime sodium is administered subcutaneously (s.c.) or intramuscularly (i.m.) for 3 months to rats (100, 300 or 900 mg/kg/day) followed by a recovery period, and also for 6 months to rats and dogs (50, 150 or 450 mg/kg/day) and for 1 month to monkeys (150 or 450 mg/kg/day), there are no serious toxic effects in all tests. In rats large doses cause some increase in urine volume and electrolyte excretion, and slightly aggravates an age related nephropathy. Administration to rats intravenously (i.v.) for 1 month of up to 400 mg/kg/day has no toxic effects. In reproduction studies on mice and rabbits there are no adverse effects on fertility, organogenesis or the rearing of young[1].

存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度: Ethanol : < 1 mg/mL (insoluble or slightly soluble)
DMSO : 19 mg/mL


关键字: Cefuroxime sodium | Staphylococcus aureus | Escherichia coli | Bacterial | S. aureus | inhibit | Streptococcus pyogenes | Cefuroxime | Antibiotic | S. faecalis | Inhibitor | β-lactamase

相关产品: Urethane | Fosfomycin Tromethamine | N2-Acetylaciclovir | S-Methyl methanesulfonothioate | 6-Ethoxychelerythrine | Protocatechualdehyde | Ciprofloxacin monohydrochloride | Bisdionin C | Chloramphenicol | Pristimerin

相关库: FDA-Approved Drug Library | Drug Repurposing Compound Library | Approved Drug Library | Antibiotics Library | Beta-Lactam Compound Library | Anti-Bacterial Compound Library | Orally Active Compound Library | NO PAINS Compound Library | Bioactive Compound Library | Anti-Infection Compound Library